{"title":"Before ruining millions of vaccines, Emergent failed inspections, raked in cash","link":"https://arstechnica.com/?p=1766272","date":1621463953000,"content":"<div>\n<figure><img src=\"https://cdn.arstechnica.net/wp-content/uploads/2021/05/GettyImages-1232984971-800x533.jpeg\" /><p><a href=\"https://cdn.arstechnica.net/wp-content/uploads/2021/05/GettyImages-1232984971.jpeg\">Enlarge</a> <span>/</span> Robert Kramer, President and Chief Executive Officer of Emergent BioSolutions, speaks via videoconference during a House Select Subcommittee on the Coronavirus Crisis hearing in the Rayburn House Office Building on Capitol Hill on May 19, 2021, in Washington, DC. (credit: <a href=\"https://www.gettyimages.com/detail/news-photo/representative-mariannette-miller-meeks-listens-as-robert-news-photo/1232984971?adppopup=true\">Stefani Reynolds-Pool / Getty Images</a>)</p>  </figure><div><a name=\"page-1\"></a></div>\n<p>When contract-manufacturer Emergent BioSolutions contaminated at least 15 million doses of Johnson &amp; Johnson’s COVID-19 vaccine and millions more doses of AstraZeneca’s vaccine at its Baltimore facility earlier this year, the company had been collecting monthly payments of $27 million from the US government—payments intended to help Emergent avoid just such a manufacturing disaster.</p>\n<p>That’s according to a <a href=\"https://coronavirus.house.gov/news/press-releases/clyburn-and-maloney-release-initial-findings-investigation-emergent-biosolutions\">preliminary report from a Congressional investigation</a>, conducted by two House committees—the Select Subcommittee on the Coronavirus Crisis and the Committee on Oversight and Reform. The report was released today and includes a number of troubling new details about the ongoing Emergent scandal.</p>\n<p>The monthly “reservation fees” Emergent received were paid out of a questionable $628 million contract from May 2020. The money was intended to help Emergent maintain a state of “cleanliness and readiness” to produce vaccine under proper manufacturing standards and practices. But, <a href=\"https://arstechnica.com/science/2021/04/contractor-that-ruined-15m-doses-of-jj-vaccine-hiked-price-of-another-by-800/\">as Ars previously reported</a>, an inspection by the Food and Drug Administration in April found that to be far from the case.</p></div><p><a href=\"https://arstechnica.com/?p=1766272#p3\">Read 13 remaining paragraphs</a> | <a href=\"https://arstechnica.com/?p=1766272&amp;comments=1\">Comments</a></p>","author":"Beth Mole","siteTitle":"Ars Technica","siteHash":"5b0ddf6e8923e49262a7894cfd77962733e43fbcc565a103b48373820b310636","entryHash":"5f3eb420b0241d172d5996d78749cfdeb5aec9c1fdc8512a64124fe3812f310d","category":"Tech"}